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metabolic syndrome; heart; sarco(endo)plasmic reticulum Ca 2ϩ -ATPase 2a; calcium; oxidative stress METABOLIC SYNDROME (MetS) is a complex disorder combining central obesity, hypertriglyceridemia, hypertension, and insulin resistance. It has been suggested that the underlying factors of MetS are obesity and insulin resistance, which can lead to further cardiac dysfunction, eventually resulting in the development of more severe diseases, such as type 2 diabetic cardiomyopathy and congestive heart failure (CHF). insulin resistance-related cardiomyopathy has been described as an early left ventricular (LV) diastolic dysfunction that develops before impaired systolic function (19, 39) .
Studies (17, 22, 47, 49) in high-fat or sucrose diet-fed animals, which develop insulin resistance and other components of MetS, have shown that cardiac diastolic dysfunction is associated with abnormalities of excitation-contraction coupling (ECC), including prolonged contraction, delayed relaxation, and slowed cytosolic Ca 2ϩ removal. Similar alterations in ECC have been described in cardiomyocytes from type 1 and 2 diabetic animals and have been related to impaired sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA2a) and Na ϩ /Ca 2ϩ exchanger (NCX) function (1, 4, 29, 37) . In MetS, very little is known about the molecular mechanisms underlying diastolic dysfunction. However, recent evidence suggests that it may involve decreased SERCA2a activity, which is not due to changes in its expression (47, 49 ). Yet, the molecular causes of impaired SERCA2a activity in MetS have not been clarified.
It has been shown that structural changes produced by oxidative posttranslational modifications (OPTMs) in SERCA2a lead to inhibition of its activity (32, 33, 43) . Indeed, it has been reported that myocyte contractile dysfunction in CHF is associated with increased ROS production and OPTMs in different proteins involved in ECC, among them SERCA2a (33, 45) . MetS is also characterized by exacerbated ROS production, which contributes to the development of ventricular dysfunction and oxidative cardiac damage (15, 20, 39) . However, the effects of elevated oxidative stress on SERCA2a activity have not been clarified. Therefore, the aim of this study was to establish the relationship among impaired SERCA2a activity, elevated oxidative stress, and Ca 2ϩ mishandling induced by MetS in the heart. Additionally, since phosphorylation of phospholamban (PLB) regulates SERCA2a activity and this can be modified by oxidative stress (31), we assessed basal PLB phosphorylation in the MetS heart.
MATERIALS AND METHODS
All protocols were approved by the Internal Institutional Committee for the Care and Use of Laboratory Animals and followed the regulations established in the Mexican Official Norm for the Use and Care of Laboratory Animals (NOM-062-ZOO-1999).
Animals
Male Wistar rats (250 g) were randomly divided into two groups: sucrose-fed rats (group 1), which were given 30% sucrose in their drinking water for a period of 16 -18 wk, and control rats (group 2), which were given tap water for the same period. All animals were housed under controlled laboratory conditions (25°C, 12:12-h lightdark cycle) and allowed ad libitum access to commercial rat chow (Purina Lab Diet 5008).
MetS Parameters
At the end of the treatment period, the following parameters were measured to assess the development of MetS.
Arterial pressure. Systolic blood pressure and diastolic blood pressure were measured by the indirect tail-cuff method using an LE5002 noninvasive blood pressure meter (Panlab, Harvard Apparatus) as previously described (38) .
Serum biochemical parameters. Rats were fasted overnight and anesthetized with pentobarbital sodium (50 mg/kg ip). Blood samples were collected from the femoral artery, and serum was separated by centrifugation and stored at Ϫ70°C. Serum triglycerides were determined using a commercial kit (TR0100, Sigma-Aldrich). Insulin was assessed using an ELISA kit (ALPCO Diagnostics). Glucose was determined by means of an assay kit (Sigma-Aldrich). Insulin resistance was evaluated by the homeostatic model assessment (HOMA) index (13) .
Retroperitoneal adipose tissue. The retroperitoneal adipose pads were carefully dissected from anesthetized animals and weighed as previously described (38) .
Isolation of LV Myocytes
LV myocytes were isolated using a standard enzymatic technique, as previously described (25) . Briefly, the heart was removed from the thoracic cavity of anesthetized rats, placed in a Langendorff system, and perfused with Ca 2ϩ -free digestion solution (DS) supplemented with 0.1 mmol/l EGTA at 37°C for 3 min. DS (pH 7.4) contained (in mmol/l) 130 NaCl, 1 lactic acid, 5.4 KCl, 3 pyruvic acid, 25 HEPES, 1 MgCl2, 0.33 NaH2PO4, and 22 glucose. The heart was then perfused with DS supplemented with 1 mg/ml collagenase type 2 (Worthington Biochemical) and 0.05 mmol/l CaCl2 for 5-8 min. The LV was removed and received in DS supplemented with 250 mg BSA and 0.083 mmol/l CaCl2. Cells were mechanically dispersed, filtered, centrifuged at 500 rpm for 2 min, and resuspended in DS supplemented with 100 mg BSA and 0.25 mmol/l CaCl 2. Afterward, myocytes were washed and resuspended in DS supplemented with 0.5 mmol/l CaCl2. Finally, myocytes were resuspended and maintained in DMEM at room temperature until use, the same day of the dissociation.
Determination of ROS
Basal ROS production was determined in isolated LV myocytes from sucrose-fed and control rats using the fluorescent indicator 2=,7=-dichlorofluorescein diacetate (DCFDA) (45) . To this end, cells were incubated with DCFDA (10 mol/l) in the dark at room temperature for 30 min. DCFDA-loaded cells were placed in a recording chamber on top of an inverted microscope and perfused with Tyrode solution (pH 7.4) containing (mmol/l) 140 NaCl, 5 KCl, 10 HEPES, 1 MgCl 2, 1.8 CaCl2, and 10 glucose. Confocal images (x-y), comprising the entire cell, were obtained by using a confocal system (Olympus Fluoview FV1000). Cells were excited with a 488-nm light from an argon laser, and the emitted fluorescence was collected at Ͼ505 nm. Fluorescence was recorded before and after a brief application of 30 mmol/l H 2O2 (30 s) in all cells. H2O2 was locally applied using a micropipette (TW100F-4, WPI) placed close to the cell and ejected with pneumatic pressure (7 psi) exerted with a PV830 PicoPump (WPI). Data are presented as basal fluorescence obtained after background subtraction (⌬F 0) normalized to the maximum fluorescence produced by H2O2 minus its background (⌬Fmax). In some experiments, cells were pretreated with the antioxidant N-acetylcysteine (NAC; 1 mmol/l, 30 min) by the addition of 10 l from a stock NAC solution (100 mmol/l dissolved in deionized water) per 1 ml of cell suspension. NAC was selected due to its ability to safely enter the cell, reduce protein residues, and scavenge most of the ROS produced in cells (2, 9) . Fluorescence intensity was measured using ImageJ software.
Recording of Intracellular Ca 2ϩ Transients
Electrically stimulated Ca 2ϩ transients were recorded in LV myocytes from sucrose-fed and control rats using the fluorescent Ca 2ϩ dye fluo4-AM. To this end, cells were incubated with 10 mol/l fluo4-AM in the dark at room temperature for 30 min. Loaded cells were placed in a recording chamber on top of an inverted microscope equipped with the confocal system described above. Cells were continually perfused with normal Tyrode solution during the experiments. To evoke electrically stimulated Ca 2ϩ transients, cells were field stimulated at 0.3 Hz until the response reached steady state. Cells were then scanned using the 488-nm argon laser in line-scan mode. Line-scan images were acquired parallel to the longitudinal cell axis at a sampling rate of 20 s/pixel. In some cases, cells were treated with NAC (1 mM, 30 min) before the experiments began. Data are presented as fluorescence intensity normalized to basal fluorescence (F/F 0). The peak amplitude (F/F0) and time to 50% decay (DT50) of the Ca 2ϩ transients were obtained using ImageJ and SigmaPlot software.
Assessment of In Situ SERCA2a-Mediated Ca 2ϩ Uptake
SERCA2a-mediated Ca 2ϩ reuptake was evaluated in LV myocytes using a previously described protocol (7, 21 
Western Blot Analysis
Western blot analysis was performed to determine the relative expression of SERCA2a and PLB as well as PLB phosphorylation in LV tissue from sucrose-fed and control rats. Animals were anesthetized with pentobarbital sodium (50 mg/kg ip), and hearts were excised. The LV was dissected and snap frozen in liquid nitrogen before homogenization with cold lysis solution (4°C). For SERCA2a, the lysis solution (pH 8.2) contained 100 mmol/l aminocaproic acid and protease inhibitors. For PLB, the lysis solution (pH 8) contained (mmol/l) 150 NaCl, 50 Tris, 5 EDTA, 1 MgCl 2, 1 DTT, 5 Na3VO4, and 10 NaF with 0.3% Triton X-100, 1% Nonidet P-40, and protease inhibitors. Proteins were separated with 10% SDS-PAGE for SERCA2a or 7-20% gradient SDS-PAGE for PLB, transferred to polyvinylidene difluoride membranes, and probed with monoclonal anti-SERCA2 (1:2,000, Thermo Scientific), anti-PLB (1:3,000, Santa Cruz Biotechnology), anti-phospho-Ser 16 PLB (1:500, Santa Cruz Biotechnology), or anti-phospho-Thr 17 PLB (1:1,000, Santa Cruz Biotechnology) antibodies. Blots were revealed with a chemiluminescence assay, and the amount of protein was analyzed using Quantity One software (Bio-Rad). Actin was used as a loading control.
Biotinylated Iodoacetamine Labeling
Free reactive thiols in SERCA2a were labeled with biotinylated iodoacetamide (BIAM; Invitrogen Molecular Probes) as previously described (32) . Briefly, frozen ventricles were homogenized in lysis buffer (pH 8.2) that contained 100 mM aminocaproic acid, protease inhibitors, and 100 mM BIAM. The homogenate was centrifuged at 14,000 rpm, and ␤-mercaptoethanol (50 mM) was added to stop further thiol reactions. Proteins were passed through a Sephadex-G25 column to remove excess BIAM, and the amount of protein was determined using the Lowry method. BIAM-labeled proteins were separated from total protein (500 g) using streptavidin-agarose beads (60 l, Sigma-Aldrich) overnight at 4°C. BIAM-labeled SERCA2a was detected by Western blot analysis using a monoclonal anti-SERCA2 antibody as described above in Western Blot Anaysis.
Statistical Analyses
Data are presented as mean Ϯ SE. Statistical analysis was carried out using unpaired Student's t-tests or two-way ANOVA followed by Student-Newman-Keuls post hoc tests as appropriate. Differences between means were considered as significant if P Ͻ 0.05. Data analysis was performed using SigmaStat software. Table 1 shows that chronic sucrose diet feeding produced a significant increase in intraabdominal fat tissue and insulin and triglyceride levels. In addition, this diet induced the development of insulin resistance, as determined by the HOMA index.
RESULTS

Effects of Diet
Glucose, systolic blood pressure, diastolic blood pressure, and body weight were not modified by the sucrose diet. These findings are consistent with our previous reports (5, 6, 15) showing that the sucrose feeding protocol used in this investigation induces some characteristics of MetS, such as central obesity, hyperinsulinemia, hypertriglyceridemia, and insulin resistance.
Basal ROS Production in MetS
We and others (15, 20) have previously shown that a sucrose diet increases oxidative stress in the myocardium. To evaluate oxidative stress, basal levels of ROS were measured in isolated LV myocytes using the indicator DCFDA. Fluorescence imaging of DCFDA-loaded myocytes showed a significant increase (6.7-fold) in the basal production of ROS in MetS compared with control myocytes (Fig. 1, A and B) . More importantly, pretreatment with the antioxidant NAC did not affect ROS levels in control myocytes (Fig. 1, A and B) , suggesting that the basal production of ROS in these cells is low. In contrast, incubation of MetS myocytes with NAC reduced ROS levels near control (Fig. 1, A and B) . These data suggest that MetS myocytes exhibit excess basal production of ROS, leading to increased oxidative stress.
Effect of Elevated Oxidative Stress on Ca 2ϩ Handling in MetS
Several studies (3, 20, 33, 45, 46) have suggested a link between elevated oxidative stress and cardiac dysfunction in Figure 2A shows representative line-scan images and the corresponding timedependent Ca 2ϩ transient profiles elicited by electrical stimulation at a low frequency (0.3 Hz) in myocytes under basal conditions. The amplitude of electrically stimulated Ca 2ϩ transients was significantly lower in MetS myocytes (F/F 0 : 3.05 Ϯ 0.29, n ϭ 5) than in control myocytes (F/F 0 : 4.81 Ϯ 0.36, n ϭ 15). These data are consistent with previous studies (20, 26) and suggest that MetS is associated with decreased systolic SR Ca 2ϩ release. NAC pretreatment restored the amplitude of electrically stimulated Ca 2ϩ transients in MetS myocytes to control levels (F/F 0 : 4.03 Ϯ 0.51, n ϭ 8), indicating the contribution of elevated oxidative stress in decreasing the amplitude of electrically stimulated Ca 2ϩ transients. In agreement with previous studies (20, 22, 49) , under basal conditions, electrically stimulated Ca 2ϩ transients decayed more slowly in MetS myocytes than in control myocytes (Fig.  2B) . The average data shown in Fig. 2C indicate that the DT 50 of electrically stimulated Ca 2ϩ transients was significantly longer in MetS myocytes than in control myocytes, indicating that cytosolic Ca 2ϩ removal is slower in the MetS heart. Treatment of control myocytes with NAC did not modify the DT 50 of electrically stimulated Ca 2ϩ transients (Fig. 2C ), consistent with low levels of ROS in these cells (Fig. 1B) . On the contrary, in MetS myocytes, NAC treatment decreased the DT 50 of electrically stimulated Ca 2ϩ transients to even lower values than those obtained in control myocytes (Fig. 2C) . These results are in agreement with the idea that ROS are increased in MetS cells (Fig. 1B) and suggest that the reduction in the cytosolic Ca 2ϩ removal rate in these cells could be attributed, at least in part, to redox modifications of the proteins involved in Ca 2ϩ clearance.
Effect of Elevated Oxidative Stress on SERCA2a Function in MetS
Impaired SERCA2a activity has been reported to play an important role in cardiac diastolic dysfunction and the prolonged duration of electrically stimulated Ca 2ϩ transients in insulin-resistant sucrose diet-fed animals (47, 49) . Accordingly, in this work, we studied the role of SERCA2a abnormalities on decreased cytosolic Ca 2ϩ removal and evaluated whether these alterations were associated with elevated oxidative stress in MetS. To this end, SERCA2a activity was assessed in LV myocytes by the DT 50 of caffeine-induced Ca 2ϩ transients, which were evoked by a rapid (1 s) application of caffeine under experimental conditions in which NCX activity was prevented (see Assessment of In Situ SERCA2a-Mediated Ca 2ϩ Uptake for details). Figure 3A shows representative line-scan images and the corresponding profiles of caffeine-induced Ca 2ϩ transients recorded in control and MetS myocytes under basal conditions. As shown in Fig. 3A , MetS myocytes exhibited prolonged caffeine-induced Ca 2ϩ transients. Figure 3B shows that the DT 50 for caffeine-induced Ca 2ϩ transients was significantly longer in MetS myocytes than in control myocytes, indicating that SERCA2a-mediated cytosolic Ca 2ϩ removal was slower in MetS myocytes. These data are consistent with those of previous studies (47, 49) and indicate that cardiac diastolic dysfunction in MetS is associated with decreased SERCA2a activity. Treatment of control myocytes with NAC did not affect the DT 50 of caffeine-induced Ca 2ϩ transients (Fig. 3B) , suggesting that SERCA2a oxidation is minimal in these cells. However, in the presence of NAC, the DT 50 for caffeine-induced Ca 2ϩ transients in MetS myocytes was reduced to control levels (Fig. 3B) . These data indicate that elevated oxidative stress in the MetS heart contributes to the impaired SERCA2a activity.
Effect of Elevated Oxidative Stress on SR Ca 2ϩ Load in MetS
It is well established that the SR Ca 2ϩ content is a major determinant of the amount of Ca 2ϩ released from the SR and the amplitude of the systolic Ca 2ϩ transient. In addition, it has been demonstrated that the SR Ca 2ϩ load is determined by the balance between SR Ca 2ϩ leak, mediated by SR Ca 2ϩ -release channels/ryanodine receptor (RyR)2, and SR Ca 2ϩ reuptake via SERCA2a (23) . Thus, decreased SERCA2a activity in MetS myocytes could alter this balance and result in a decreased SR Ca 2ϩ load, which, in turn, may explain the reduction in the amplitude of electrically stimulated Ca 2ϩ transients ( Fig. 2A) . To explore this possibility, we estimated SR Ca 2ϩ content by measuring the amplitude of caffeine-induced Ca 2ϩ transients in MetS and control myocytes (5, 16) . As shown in Fig. 3C , under basal conditions, the amplitude of caffeineinduced Ca 2ϩ transients was similar in both groups. Similarly, NAC treatment did not affect the amplitude of caffeine-induced Ca 2ϩ transients in any group. These data indicate that, despite decreased SERCA2a function and elevated oxidative stress, total SR Ca 2ϩ content is not decreased in MetS myocytes, which is consistent with a previous report (49) . Therefore, the reduction in the amplitude of electrically stimulated Ca 2ϩ transients in MetS myocytes is not associated with alterations in SR Ca 2ϩ load, indicating that other mechanisms are involved.
Expression and Oxidation Level of SERCA2a in MetS
We measured the extent of oxidized SERCA2a by BIAM labeling of free reactive thiols. Figure 4A shows immunoblot of BIAM-labeled SERCA2a from control and MetS LVs. Figure  4B shows that compared with control, the amount of BIAMlabeled SERCA2a in the MetS hearts was significantly decreased by 32.4%, indicating that in MetS there is an increased number of oxidized reactive cysteine thiols on SERCA2a. Moreover, this high level of SERCA2a oxidation was not associated with changes in protein expression (Fig. 4, C and  D) . Together, these data suggest that decreased SERCA2a activity in MetS involves OPTMs of this protein.
Expression and Phosphorylation Level of PLB in MetS
It is well established that PLB phosphorylation at Ser 16 and Thr 17 plays a critical role in ECC by regulating SERCA2a activity. Additionally, it has been reported that oxidative regulation of phosphatases may result in decreased PLB phosphorylation at Ser 16 (31) . Thus, we investigated whether changes in the basal level of phosphorylated PLB contribute to depressed SERCA2a activity induced by oxidative stress in the MetS heart. Figure 5A shows immunoblots of total and phosphorylated PLB at Ser 16 and Thr 17 from control and MetS LVs. There were no significant differences in levels of either total (Fig. 5B ) or phosphorylated PLB (Fig. 5, C and D) between control and MetS hearts. These data suggest that oxidative regulation of basal PLB phosphorylation does not contribute to the depressed SERCA2a activity in MetS.
DISCUSSION
LV diastolic dysfunction is a common clinical manifestation of myocardial alterations in patients with MetS and diabetes (19, 24, 44, 48, 52) . Recently, it has been shown that LV diastolic dysfunction is associated with abnormal cardiomyocyte active relaxation and Ca 2ϩ handling due to decreased SERCA2a function (34, 49) . In this work, we used a sucrose diet-fed rat model of MetS to explore the role of elevated oxidative stress in mediating Ca 2ϩ mishandling and impaired SERCA2a activity. Our data provide evidence showing that OPTMs of SERCA2a induced by increased production of ROS contribute to the prolonged Ca 2ϩ transients and slowed SERCA2a-mediated Ca 2ϩ reuptake in LV myocytes from MetS rats.
Increased Oxidative Stress in LV Myocytes From MetS Rats
Prior work (5, 6, 15) from our group has demonstrated that the sucrose diet feeding protocol used in this investigation induces several pathological characteristics of MetS in rats, such as central obesity, insulin resistance, hyperinsulinemia, and hypertriglyceridemia. In the present work, we confirmed these results by showing that treatment of rats with sucrose in their drinking water induces the metabolic derangements associated with MetS (Table 1 ). In addition, our group (5, 6, 15) has also demonstrated that the myocardium of these rats is exposed to increased oxidative stress due to enhanced peripherical ROS production as well as decreased antioxidant systems. In this study, we found that under resting conditions, LV myocytes from these rats exhibit higher levels of basal ROS production than myocytes from control rats (Fig. 1) . These data provide evidence showing that under basal metabolic conditions, MetS myocytes are not only exposed to a high external oxidative damage but also that metabolic alterations, such as mitochondrial dysfunction and antioxidant systems in myocytes (16) , result in enhanced ROS accumulation in situ. This extensive oxidative damage could evoke alterations in the structure and activity of myocardial proteins resulting in loss of cardiac function. Indeed, it has been shown that excessive ROS levels and oxidative damage of key proteins involved in Ca 2ϩ handling contribute to the development of cardiac dysfunction in various pathologies, including obesity, insulin resistance, diabetes, age-associated cardiomyopathies, and CHF (3, 20, 34, 45, 46) .
Increased Oxidative Stress Contributes to Impaired SERCA2a Activity and Ca 2ϩ Mishandling in Cardiomyocytes From MetS Rats
It has been demonstrated that high sucrose diet feeding in rats results in slowed ventricular myocyte relaxation, abnormal intracellular Ca 2ϩ handling, and impaired SERCA2a function (17, 22, 47, 49) . In the present work, we extended these findings by showing that elevated accumulation of ROS in LV myocytes from MetS rats contributes to these alterations. Our data indicate that 1) elevated production of ROS in MetS myocytes is paralleled by prolonged electrically stimulated Ca 2ϩ transients (Fig. 2) and slowed SERCA2a-mediated SR Ca 2ϩ reuptake (Fig. 3) and 2) treatment of MetS myocytes with an antioxidant agent (NAC) normalizes ROS production and SERCA2a-mediated SR Ca 2ϩ reuptake and not only recovers but also accelerates electrically stimulated Ca 2ϩ transients. These data are consistent with previous studies (20, 34) in sucrose diet-fed and glucose-intolerant Lep/Lep mice, where abnormal production of ROS and elevated protein oxidative damage were implicated in altered SR Ca 2ϩ reuptake and following development of cardiac dysfunction. On the other hand, the unexpected acceleration in the decay phase of electrically stimulated Ca 2ϩ transients after NAC treatment in MetS myocytes suggests that the function of other components that contribute to cytosolic Ca 2ϩ removal, besides SERCA2a, is increased once redox balance is recovered in these cells.
Decreased SERCA2a Activity in Cardiomyocytes From MetS Rats Is Not Associated With Changes in SR Ca 2ϩ Load
It has been shown that type 2 diabetic cardiomyopathy is not only characterized by diastolic dysfunction but also involves a late systolic dysfunction reflected by depressed myocyte contractility (12) . This contractile dysfunction has been associated with diminished myocyte SR Ca 2ϩ load and a subsequent decrease in the amplitude of systolic Ca 2ϩ transients (8, 12, 37) . Cardiac contractile dysfunction has also been observed in rats suffering from insulin resistance (14, 17, 22, 26, 47, 49) , but the molecular causes of this alteration are much less clear. In this study, we found that MetS myocytes exhibit depressed electrically stimulated Ca 2ϩ transients ( Fig. 2A) myocytes is not altered (Fig. 3C ) despite a decrease in SERCA2a activity (Fig. 3B) . Moreover, NAC treatment does not modify SR Ca 2ϩ load in MetS myocytes, although it causes a significant recovery in the amplitude of electrically stimulated Ca 2ϩ transients and SERCA2a activity. These data suggest that enhanced ROS production in MetS may affect other proteins involved in determining the SR Ca 2ϩ load and systolic SR Ca 2ϩ release. As previously demonstrated, RyR2 plays an important role during resting conditions to balance SERCA2a activity and by this means maintains the SR Ca 2ϩ load and during ECC to determine the amplitude of Ca 2ϩ transients (23) . Accordingly, to explain our results, we propose that the increased ROS levels in MetS myocytes decrease not only SERCA2a activity but also RyR activity. The latter may contribute to maintain the SR Ca 2ϩ load and also to the decreased amplitude of electrically stimulated Ca 2ϩ transients. In fact, depressed RyR2 activity without changes in protein expression have been observed in MetS dogs (18) , and there is enough evidence to support that OPMTs modulate RyR2 activity (45, 53) .
Oxidative Modifications of SERCA2a Contribute to Impaired Activity in Cardiomyocytes From MetS Rats
Decreased SERCA2a function has been observed in several animal models of insulin resistance and type 2 diabetes; however, the molecular causes of this defect are not completely clear. Usually depressed SERCA2a activity is the result of either decreased protein expression or changes in the molecular structure that regulate its activity. In different models of type 2 diabetes, it has been reported that impaired SERCA2a activity is paralleled by either decreased SERCA2a mRNA or protein levels (1, 4, 41) . In contrast, decreased SERCA2a activity with no changes in protein content has been reported in different insulin resistance models (34, 49) . In insulin-resistant Lep/Lep mice, Li and coworkers (34) demonstrated that decreased Ca 2ϩ reuptake in cardiac SR microsomes is accompanied by OPTMs of SERCA2a. Similarly, our data show that the slowed SERCA2a-mediated SR Ca 2ϩ reuptake in MetS myocytes is not caused by alterations of protein expression (Fig. 4) . Interestingly, SR Ca 2ϩ reuptake is corrected by NAC (Fig. 3) , suggesting that OPTMs may be responsible for the decreased SERCA2a activity. This idea was further supported by the low BIAM-SERCA2a labeling in the myocardium from MetS rats (Fig. 4) , which indicates an increased number of oxidized reactive cysteine thiols (51) .
In vitro studies (28, 32, 35, 50) have demonstrated a relationship between elevated ROS levels and OPTMs of SERCA2a associated with decreased activity. In addition, in rodent models of CHF and aging, it has been demonstrated that increased ROS levels are accompanied by a loss of SERCA2a activity, increased sulfonylation at Cys , and decreased free sulfhydryl content (3, 30, 33) . In agreement with these findings, our data show that decreased SERCA2a activity in MetS rats is related to elevated ROS production and increased oxidative modifications of reactive cysteine thiols, indicating that impaired SERCA2a function may be caused by oxidative modifications, including Cys 674 (51) . These data strongly support that elevated ROS production in MetS is important for cellular heart dysfunction.
It is important to point out that under our experimental conditions, the impaired SERCA2a activity observed in the MetS heart cannot be explained by alterations in the total expression or basal state of PLB phosphorylation (Fig. 5) . These results are in agreement with those reported by Wold and coworkers (49) indicating no changes in either the expression or phosphorylation of PLB in myocytes from sucrose diet-fed rats and suggest that the main mechanism involved in the impaired SERCA activity in the MetS heart is an alteration in the redox state of this protein. Nevertheless, in the present study, we did not address the specific OPTMs that lead to depressed SERCA2a activity in the MetS heart, which will be necessary in the future to establish the precise oxidative mechanisms involved in this alteration.
Limitations of the Study
It is clear that oxidative stress plays an important role in cardiac damage during MetS. Our work demonstrates an important participation of elevated ROS levels on depressed SERCA activity in cardiomyocytes, which, in turn, has been reported to affect cardiac function. Moreover, antioxidant treatment of cardiomyocytes with NAC virtually reverses this damage, indicating the oxidative nature of these alterations and, notably, a reversibility of the damage, at least during early stages of MetS. Although our data suggest that antioxidative therapy with NAC can be useful in the treatment of cardiac damage induced by oxidative stress, it has to be clear that our study was done in vitro, so there is no guarantee of the efficacy of NAC in vivo. Importantly, our model represents an early stage of cardiac disease, implying that during late complications, such as hypertrophy or cardiac failure, the damage could be irreversible and that functional recovery is not guaranteed even with the use of antioxidants (42) . In addition, oxidative damage could affect other proteins and tissues, compromising the function of different organs and lowering the quality of life. Indeed, at present, antioxidative therapies are a treatment option for MetS and its associated comorbidities; however, there are some controversies about their efficacy in restoring the alterations produced by MetS in humans. It has been taken in account that antioxidant therapies are initiated after the onset of severe MetS complications, when oxidative damage is most likely permanent; thus, more attention must be paid at the opportune intervention to prevent irreversible damage.
